Assessment of Early Intervention Strategies for Management of Cytokine Release Syndrome and Neurologic Events after Brexucabtagene Autoleucel ( Brexu-Cel) Treatment in Patients with Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL) in ZUMA-2

被引:0
作者
Oluwole, Olalekan O. [1 ]
Reagan, Patrick M. [2 ]
Miklos, David B. [3 ]
Locke, Frederick L. [4 ]
Goy, Andre [5 ]
Jacobson, Caron A. [6 ]
Munoz, Javier L. [7 ]
Forcade, Edouard [8 ]
Topp, Max S. [9 ]
Zheng, Dan [10 ]
Nunes, Ana [10 ]
Zhang, Wangshu [10 ]
Shen, Rhine R. [10 ]
Kloos, Ioana [10 ]
Kersten, Marie Jose [11 ]
Wang, Michael L. [12 ]
机构
[1] Vanderbilt Univ, Div Hematol Oncol, Med Ctr, Nashville, TN USA
[2] Univ Rochester, Sch Med, Rochester, NY USA
[3] Stanford Univ, Div Blood & Marrow Transplantat & Cellular Therap, Palo Alto, CA USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA
[5] Hackensack Meridian Hlth, Lymphoma Div, John Theurer Canc Ctr, Hackensack, NJ USA
[6] Dana Farber Canc Inst, Boston, MA USA
[7] Banner MD Anderson Canc Ctr, Phoenix, AZ USA
[8] CHU Bordeaux, Serv Hematol Clin & Therapie Cellulaire, F-33000 Bordeaux, France
[9] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[10] Gilead Co, Kite, Santa Monica, CA USA
[11] Amsterdam UMC, Locat Univ Amsterdam, Canc Ctr Amsterdam, HOVON LLPC, Amsterdam, Netherlands
[12] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
关键词
D O I
10.1182/blood-2023-174681
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:7
相关论文
empty
未找到相关数据